Open AccessA prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin's Ranibizumab with Lucentis® in patients with neovascular age-related macular degeneration
Author(s) -
Chirag P. Shah,
Ramandeep Singh,
Rajeev Kumar Chauhan,
Ashish Saxena,
Anup Shah,
Laxshmi Mondal,
Dhananjay Bakhle,
Arti N. Shah,
Shashank Deoghare,
Neelakant Krishnan,
Neelima Godse
Publication year - 2022
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/ijo.ijo_2118_21
Subject(s) - medicine , ranibizumab , macular degeneration , visual acuity , clinical endpoint , adverse effect , prospective cohort study , population , randomized controlled trial , ophthalmology , cohort , surgery , bevacizumab , chemotherapy , environmental health